Announcements Trials

Browse Landscape

Phase

Phase NA 5 Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Breast 5 Thoracic 3 Other hematologic neoplasm 3 Genitourinary 3 CNS 3 Tumor-Agnostic 2 Sarcoma 2 Plasma cell 2 Lymphoid 2 Gynecologic 2 Dermatologic 2 Myeloid 1 Endocrine 1

Conditions

Polycythemia Vera 1

Interventions

Cyclophosphamide 143 fludarabine phosphate 130 Busulfan 109 Tacrolimus 94 fludarabine 93 Mycophenolic Acid 90 Whole-Body Irradiation 84 Peripheral Blood Stem Cell Transplantation 81 Imatinib Mesylate 69 Antilymphocyte Serum 67 Cyclosporine 66 Azacitidine 64 Cytarabine 63 Methotrexate 60 Melphalan 60 Filgrastim 50 Granulocyte Colony-Stimulating Factor 40 Decitabine 40 Thiotepa 38 thymoglobulin 34 Stem Cell Transplantation 34 Dasatinib 34 Radiotherapy 33 nilotinib 31 ruxolitinib 28 Cord Blood Stem Cell Transplantation 28 venetoclax 26 Clofarabine 25 Specimen Handling 24 Methylprednisolone 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Blood Specimen Collection × Myeloid × Clear all

NCT03003325 2024-09-19

Low-PV

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Phase 2 Completed

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡